News
Bioberica Farma has launched DUARTRON, the only glucosamine on the market sold in hard gelatine capsules, a dosage form preferred by patients because of its ease of use. Furthermore, Duartron® is funded by the Spanish National Health System. Osteoarthritis is a disease affecting a large percentage of the population. In Spain, for instance, is the third most common chronic disease.
Bioiberica again attended the annual congress hosted by New Ag International journal.
Bioiberica just opened a new production site of Heparin derivatives within the expansion plan of its Science portfolio.
- The SECA and Bioiberica Farma will again award the Innova prizes to recognize the work of innovative projects contributing to improvements in osteoarthritis management and patient care.
- Deadline for candidature submissions is July 31st 2014. The two prizes, each worth 10,000€, will be awarded on October 16th, during the SECA annual congress.
Our veterinary division was present at the 10th congress of the Montenegro veterinary hospital, which was held at Santa Maria da Feira (Portugal) on February 8-9. More than 2,200 visitors attended the congress.